Albert Renold Travel Fellowships enable scientists and clinicians to travel and stay at other institutions in order to learn specific techniques or clinical skills required for the advancement of their diabetes research project and not available at their home institution. The home and/or the host institution must be based in Europe or a Europe-associated country […]
EFSD has established this independent research programme called the EFSD/Boehringer Ingelheim European Research Programme on “Multi-System Challenges of Diabetes” to encourage projects aimed at advancing current knowledge in the inter-organ crosstalk and related pathophysiology in Diabetes and its complications through innovative basic or clinical research. This EFSD/Boehringer Ingelheim European Diabetes Research Programme is intended to
Through its Prevention beyond the pipeline Program,The ADDF seeks to support studies of cognitive symptoms due to health conditions, comparative effectiveness research, and epidemiological studies that probe whether the use or choice of drugs alters the risk for dementia or cognitive decline. Duration: Multi-year Average award: Up to $3,000,000 for clinical trials based on stage
Alzheimer’s Drug Discovery Foundation – Prevention pipeline Leggi tutto »
The Lupus Innovation Award (formerly known as the Novel Research Grant): up to $150,000/year total costs for up to 2 years. Provides support for pioneering, high-risk, high-reward approaches to major challenges in lupus research. Special emphasis is placed on lupus studies exploring fundamental mechanisms, novel targets and pathways, novel technologies, and interdisciplinary approaches. Both early career and established investigators new to
Lupus Reserch Alliance – Lupus Innovator Award Leggi tutto »
The EASD Rising Star Symposium and EFSD Rising Star Fellowship Programme aims to identify promising and innovative young researchers who are developing their research activities in Europe. Selected candidates will have the opportunity to present an overview of their past and ongoing research activities during a multidisciplinary research symposium at the EASD Annual Meeting. The
EASD Rising Star Symposium and EFSD Rising Star Fellowship Programme Leggi tutto »
The EFSD/Novo Nordisk Partnership for Diabetes Research in Europe Programme will accept applications from all fields of diabetes research including both basic and clinical research. Research will be supported through the award of grants of up to € 100,000 for basic and or clinical projects. Applications with a funding requirement larger than that specified above
EFSD and Novo Nordisk A/S Programme for Diabetes Research in Europe Leggi tutto »
Given the pathological heterogeneity of Alzheimer’s disease and related dementias, new biomarkers are needed to more accurately characterize specific underlying pathophysiology. This RFP seeks to support the development of CSF and neuroimaging biomarkers for multiple contexts of use (see below) that include but are not limited to: Demonstrate target engagement for novel therapeutics Biomarkers that
Each year, FRAXA funds $1 million or more in medical research aimed at finding specific treatments and ultimately a cure for fragile X syndrome. Our goal is to bring practical treatment into current medical practice as quickly as possible; so preference is given to projects that have a clear practical application and the results of which will
Fraxa Research Foundation – Fragile X Research Grants Leggi tutto »
The Oxalosis and Hyperoxaluria Foundation invites applications for its research grants. These support research that will lead to new diagnostics, treatments and a cure for primary hyperoxaluria and related hyperoxaluria conditions. Applicants must hold a MD, PhD or equivalent by the start of the funding period and have an appointment at an academic institution. Each
Oxalosis and Hyperoxaluria Foundation – Research grants Leggi tutto »
L’Innovative Health Initiative (IHI) ha pubblicato le tematiche in corso di esame per i prossimi bandi IHI 6 e 7 con lancio previsto a inizio 2024. Per quanto riguarda la call IHI 6, articolata in due fasi, verranno considerati i seguenti topic: Sostegno alla resilienza del sistema sanitario attraverso un focus sulla permanenza di malattie croniche nel trattamento Sviluppo di indicazioni e raccomandazioni
